Suppr超能文献

优化药物治疗心力衰竭患者的运动训练计划对心脏神经元功能的影响:一项碘-123 间碘苄胍闪烁显像研究的随机分组。

Impact of an exercise training program on cardiac neuronal function in heart failure patients on optimal medical therapy : A randomized Iodine-123 metaiodobenzylguanidine scintigraphy study.

机构信息

Department of Cardiology, Stavanger University Hospital, Armauer Hansens vei 20, PO Box 8100, 4068, Stavanger, Norway.

Department of Clinical Science, University of Bergen, Bergen, Norway.

出版信息

J Nucl Cardiol. 2018 Aug;25(4):1164-1171. doi: 10.1007/s12350-016-0724-8. Epub 2017 Jan 17.

Abstract

BACKGROUND

The syndrome of heart failure (HF) is characterized by left ventricular dysfunction and a compensatory chronic over activation of the sympathetic nervous system. We wanted to investigate if the beneficial effects of exercise training (ET) in HF patients on optimal medical therapy (OMT) are associated with alterations in cardiac sympathetic activity.

METHODS

Cardiac sympathetic activity was evaluated at baseline and after 12 weeks using metaiodobenzylguanidine scintigraphy in 23 patients with stable HF participating in the SmartEx trial. Patients with HF in New York Heart Association class II or III and left ventricular ejection fraction <35 % were randomized to three different ET groups.

RESULTS

We found no statistically significant changes in cardiac sympathetic activity after 12 weeks of ET. Heart to mediastinum (H/M) ratio at 15 minutes (0.00174 ± 0.0841, P = 0.922), H/M ratio at 4 hours (-0.00565 ± 0.1163, P = 0.818) and washout ratio (WR) (-1.2666 ± 16.5412, P = 0.717). A further group-wise analysis of the three ET groups did not show any difference between the groups.

CONCLUSION

A 12-week ET program did not alter the abnormal cardiac sympathetic activity in stable HF patients on modern OMT.

摘要

背景

心力衰竭(HF)的综合征特征为左心室功能障碍和交感神经系统的慢性代偿性过度激活。我们想研究在接受最佳药物治疗(OMT)的稳定心力衰竭患者中,运动训练(ET)的有益效果是否与心脏交感神经活动的改变有关。

方法

在 SmartEx 试验中,23 名稳定心力衰竭患者接受了为期 12 周的 metaiodobenzylguanidine 闪烁显像,以评估基线和 12 周后的心脏交感神经活性。纽约心脏协会(NYHA)心功能分级 II 或 III 级且左心室射血分数<35%的心力衰竭患者被随机分为 3 个不同的 ET 组。

结果

我们发现 12 周 ET 后心脏交感神经活性没有统计学上的显著变化。15 分钟时心脏与纵隔(H/M)比值(0.00174±0.0841,P=0.922)、4 小时时 H/M 比值(-0.00565±0.1163,P=0.818)和洗脱率(WR)(-1.2666±16.5412,P=0.717)。对三个 ET 组的进一步组间分析显示,组间无差异。

结论

12 周的 ET 方案并未改变接受现代 OMT 的稳定心力衰竭患者异常的心脏交感神经活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验